Jackson Creek Investment Advisors LLC Macrogenics Inc Transaction History

Jackson Creek Investment Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$15.91 - $21.88 $661,315 - $909,464	-41,566 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$19.74 - $28.7 $7,915 - $11,508	401 Added 0.97%	41,566 $870,000
Q2 2021 Aug 03, 2021	SELL	$20.49 - $35.63 $72,473 - $126,023	-3,537 Reduced 7.91%	41,165 $1.11 Million
Q1 2021 May 27, 2021	BUY	$18.99 - $33.2 $848,890 - $1.48 Million	44,702 New	44,702 $1.42 Million

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.